AGORA Cancer Research Center

AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).

Latest news

Events

AGORA PRS Seminar | May 27th

More information

Events

FameLab Event in Lausanne | May 28

More information

Events

Lola and John Grace Distinguished Lecture in Cancer Research, Prof. Scott Lowe | June 5th

More information

Events

Ludwig Distinguished Lecture, Dr. Joe Yeong Poh Sheng | June 12th

More information

Highlighted publication

Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure

Hope HC, de Sostoa J, Ginefra, (…), Coukos G, Migliorini D, Vannini N

Nature Cancer – 2025 May 20

Events

Ludwig Distinguished Lecture, Prof. Chris Goodnow | June 19th

More information

Highlighted publication

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

Dong Y, Saglietti C, Bayard Q, (…), Gottardo R, Homicsko K, Madissoon E

Nature communications – 2025 May 12

News

Welcoming Professor Etienne Meylan to AGORA

Events

ISREC-SCCL Symposium 2025 | September 1–4

Register

Events

AGORA Tumor Microenvironment Journal Club

More information

Highlighted publication

HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic Vaccine.

Lecointre M, Guillot J, Marcone R, (…), Fournier N, Homicsko K, Hanahan D

Cancer discovery – 2025 Apr 27

News

Prof. Douglas Hanahan Receives Pezcoller-AACR Award

Past news

Latest publications

Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer.

Apavaloaei A, Zhao Q, Hesnard L, (…), Bassani-Sternberg M, Thibault P, Perreault C

Nature cancer – 2025 May 22

Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure

Hope HC, de Sostoa J, Ginefra, (…), Coukos G, Migliorini D, Vannini N

Nature Cancer – 2025 May 20

Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target.

Ahmad ST, Li Y, Garcia-Lopez J, (…), Kutscher LM, Lin H, Northcott PA

Cancer cell – 2025 May 14

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

Dong Y, Saglietti C, Bayard Q, (…), Gottardo R, Homicsko K, Madissoon E

Nature communications – 2025 May 12

Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis.

Dang D, Deogharkar A, McKolay J, (…), Simoes-Costa M, Northcott PA, Venneti S

Cancer cell – 2025 May 12